Title: support for specific pathogen free indian-origin rhesus macaque colonies period: june 20, 2019 - june 19, 2024

Ended Awarded Last action

Contract number
75N93019F00131
Awardee
Awarding agency
Obligated
$2,073,194

Award facts

Opportunity
Contract value 88% obligated
  • $2,073,193.60 Current, with exercised options
  • $2,356,873.60 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
112990 All Other Animal Production
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Yemassee, SC, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00007 -$9,154
Exercise an Option P00006 $551,151
Exercise an Option P00005 $536,551
Exercise an Option P00004 · Support for specific pathogen free indian-origin rhesus macaque colonies $130,488
Funding Only Action P00003 $91,138
Exercise an Option P00002 $391,463
Modification $254,370
Other Administrative Action P00001 $127,186

About this award

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Delivery Order contract to Alpha Genesis Inc., a for-profit subchapter S corporation, for the provision of specific pathogen free Indian-origin rhesus macaques and associated support services over a 5-year period from June 20, 2019 to June 19, 2024. The contract, issued under the Rhesus Macaque Breeding Program 2019 indefinite delivery/indefinite quantity (IDIQ) contract vehicle, has a total potential value of $2,356,873.60. Alpha Genesis, which has a history of providing nonhuman primates and related services to support biomedical research across federal agencies, will maintain a breeding colony of the required rhesus macaques at its facility in Yemassee, South Carolina to fulfill task orders under this contract. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract 75N93019F00131?

75N93019F00131 was awarded to Alpha Genesis Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 20, 2019.

How much is contract 75N93019F00131 worth?

The government has obligated $2,073,194 on 75N93019F00131. Its potential value, with all options, is $2,356,874.

Is contract 75N93019F00131 an order under another contract?

Yes. 75N93019F00131 is a delivery order under 75N93019D00032, an indefinite delivery contract, on Rhesus Macaque Breeding Program 2019.

Was contract 75N93019F00131 competed?

The extent of competition for 75N93019F00131 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award